http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HK-1214134-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-006
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-205
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K-
filingDate 2016-02-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_060f3e39c7f8ac84d648246ddeeb4747
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aa3dd88af345d59f5445b0cc5a82ee54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec7945c968751ea22a9e34b4bdea3fb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86974a9d60797721da00b246f5105d5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53f465f6d4c441a7d51216c464a15a42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b78cacdeb13476ab7c53f97c08eb453
publicationDate 2016-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber HK-1214134-A1
titleOfInvention Transmucosal administration of glatiramer acetate
priorityDate 2012-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID448746680
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3081884

Total number of triples: 24.